Seagate Slips, NextEra Lower, Regeneron Tumbles | Stock Movers
May 18, 2026•Channel
AI Analysis
Data from YouTube Data API v3•Updated Just now
Video Overview
Video Details
Published1 month ago
Duration3:54
Video IDaOacILlzhbE
Languageen
CategoryNews & Politics
PrivacyPublic
Made for KidsNo
Video TypeRegular Video
Performance Metrics
Views89
Likes2
Comments31
Engagement Rate37.08%
Likes per 100 views2.25
Comments per 1K views348.31
Video Tags
Description
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Seagate (STX) shares slumped as much as 8.3% after management comments at a JPMorgan conference sparked investor fears that the company won’t be able to keep up with soaring demand for memory chips. Chief Executive Officer Dave Mosley said building new factories would “take too long” and potentially set up the company with more capacity than it needs when asked during a Monday presentation whether Seagate plans to expand manufacturing capacity.
- NextEra (NEE) agreed to pay about $67 billion in stock for Dominion Energy in the biggest power acquisition ever, creating a giant utility extending from Florida to the artificial intelligence data centers clustered in Virginia. The scope of the transaction underscores how the spike in AI-driven power demand is pushing the utilities sector to seek ever-greater size and clout. The deal would position NextEra as the dominant utility in a region that’s struggling to meet the surge in electricity consumption. Dominion shares rose while NextEra shares fell.
- Regeneron Pharmaceuticals (REGN) shares sank more than 10%, most intraday since May 2025, after the drugmaker’s phase 3 data for fianlimab in metastatic melanoma fell short of expectations. Citi and Leerink analysts downgraded their ratings on the stock following the disappointing trial update. Regeneron’s experimental drug fianlimab couldn’t beat Merck & Co.’s established cancer blockbuster Keytruda in the study, Regeneron said late on Friday. Another head-to-head trial of the Regeneron compound versus Bristol-Myers Squibb Co.’s Opdualag continues.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers: https://www.youtube.com/playlist?list=PLe4PRejZgr0NxhJreY_kjMBdW8cvmNauU
Visit us: https://www.bloomberg.com/podcasts
Follow Bloomberg Podcasts on Twitter: https://twitter.com/podcasts
Visit our other YouTube channels:
Bloomberg Television: https://www.youtube.com/@markets
Bloomberg Originals: https://www.youtube.com/bloomberg
Quicktake: https://www.youtube.com/@BloombergQuicktake
For coverage on news, markets and more: http://www.bloomberg.com/video
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Seagate Slips, NextEra Lower, Regeneron Tumbles